We are live on
!
Find out more
AAF
Andra AP-fonden Portfolio holdings
AUM
$8.39B
1-Year Est. Return
21.19%
This Fund
S&P 500
This Quarter
Est. Return
-1.97%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.7B
AUM Growth
-$2.26B
(-57%)
Cap. Flow
-$2.19B
Cap. Flow
% of AUM
-129.26%
Top 10 Holdings %
Top 10 Hldgs %
10.18%
Holding
584
New
3
Increased
124
Reduced
125
Closed
324
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DoorDash
DASH
|
+$5.43M |
| 2 |
NXP Semiconductors
NXPI
|
+$4.93M |
| 3 |
CoStar Group
CSGP
|
+$4.85M |
| 4 |
Pool Corp
POOL
|
+$4.73M |
| 5 |
Roku
ROKU
|
+$4.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
W.W. Grainger
GWW
|
+$20.3M |
| 2 |
Fair Isaac
FICO
|
+$18.4M |
| 3 |
Gilead Sciences
GILD
|
+$18M |
| 4 |
Gartner
IT
|
+$16.7M |
| 5 |
Arrow Electronics
ARW
|
+$16.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.8% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 14.59% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Neurocrine Biosciences
NBIX
$16.6B
| $6.14M | 0.36% |
54,600
-13,300
| -20% | -$1.4M |
|
127
Alnylam Pharmaceuticals
ALNY
$29.3B
| $6.11M | 0.36% |
34,500
-6,000
| -15% | -$1.14M |
|
128
Moderna
MRNA
$23.6B
| $6.09M | 0.36% |
59,000
-3,200
| -5% | -$357K |
|
129
Cboe Global Markets
CBOE
$29.9B
| $6.08M | 0.36% |
38,900
-3,600
| -8% | -$530K |
|
130
Host Hotels & Resorts
HST
$16B
| $6.03M | 0.36% |
375,400
+74,300
| +25% | +$1.24M |
|
131
Vertex Pharmaceuticals
VRTX
$126B
| $5.98M | 0.35% |
17,200
-800
| -4% | -$280K |
|
132
Quest Diagnostics
DGX
$26.3B
| $5.91M | 0.35% |
48,500
-24,900
| -34% | -$3.32M |
|
133
C.H. Robinson
CHRW
$17.5B
| $5.86M | 0.35% |
68,000
-12,700
| -16% | -$1.19M |
|
134
Kanzhun
BZ
$7.36B
| $5.84M | 0.34% |
384,800
+14,900
| +4% | +$234K |
|
135
Mastercard
MA
$493B
| $5.82M | 0.34% |
14,700
+200
| +1% | +$80.3K |
|
136
JPMorgan Chase
JPM
$950B
| $5.82M | 0.34% |
40,100
-1,400
| -3% | -$210K |
|
137
American Homes 4 Rent
AMH
$12.5B
| $5.81M | 0.34% |
172,500
+51,600
| +43% | +$1.85M |
|
138
Synchrony
SYF
$25.6B
| $5.77M | 0.34% |
188,800
-8,200
| -4% | -$273K |
|
139
EPAM Systems
EPAM
$5.09B
| $5.75M | 0.34% |
22,500
-1,400
| -6% | -$346K |
|
140
Equinix
EQIX
$103B
| $5.74M | 0.34% |
7,900
+1,100
| +16% | +$852K |
|
141
Capital One
COF
$134B
| $5.68M | 0.33% |
58,500
+10,000
| +21% | +$1.07M |
|
142
Match Group
MTCH
$8.55B
| $5.65M | 0.33% |
144,272
+5,200
| +4% | +$231K |
|
143
Erie Indemnity
ERIE
$13.2B
| $5.64M | 0.33% |
19,200
-3,800
| -17% | -$983K |
|
144
Steris
STE
$23.1B
| $5.62M | 0.33% |
25,600
+12,600
| +97% | +$2.85M |
|
145
Regeneron Pharmaceuticals
REGN
$80.8B
| $5.6M | 0.33% |
6,800
-3,500
| -34% | -$2.75M |
|
146
Zoom
ZM
$30.6B
| $5.6M | 0.33% |
80,000
-7,900
| -9% | -$548K |
|
147
Keysight
KEYS
$58.3B
| $5.57M | 0.33% |
42,100
-6,300
| -13% | -$933K |
|
148
Ares Management
ARES
$30.9B
| $5.55M | 0.33% |
54,000
+12,200
| +29% | +$1.23M |
|
149
MINISO
MNSO
$3.75B
| $5.55M | 0.33% |
214,300
+52,800
| +33% | +$1.18M |
|
150
Pinterest
PINS
$13.4B
| $5.54M | 0.33% |
205,000
-93,200
| -31% | -$2.54M |
|
Similar funds
NW
GGHC
FT
DM
GRQ
PCM
IC
NB
Andra AP-fonden's Q3 2023 Portfolio in Review
As of Q3 2023, Andra AP-fonden held 584 positions worth $1.7B, down 57% from $3.95B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Andra AP-fonden withdrew a net $2.19B in Q3 2023, closing 324 positions and reducing 125 holdings. Its most notable exit was W.W. Grainger, an estimated $20.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Andra AP-fonden opened a new position in Sea Limited worth $440K.
- Andra AP-fonden's largest Q3 2023 buy was Sea Limited: 10,000 shares worth $440K.
- Andra AP-fonden added most to DoorDash in Q3 2023, an estimated $5.43M increase.
- Andra AP-fonden's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $5.92M.
- Andra AP-fonden fully exited W.W. Grainger in Q3 2023, selling an estimated $20.3M.
- Andra AP-fonden's ten largest holdings make up 10% of its $1.7B portfolio in Q3 2023.
- Andra AP-fonden opened 3 new positions and closed 324 in Q3 2023.
- Andra AP-fonden's portfolio value fell 57% quarter-over-quarter to $1.7B.
Based on Andra AP-fonden's 13F filing for Q3 2023, filed 9 Nov 2023.